They found the switch that makes the body attack cancer-Click HereThis common liver supplement could boost cancer treatment success-Click HereThis European treatment for joint pain just passed a major scientific test-Click HereTiny brain nanotubes found by Johns Hopkins may spread Alzheimer’s-Click HereExercise might be the key to a younger, sharper immune system-Click HereScientists grow mini human livers that predict toxic drug reactions-Click HereThis new blood test can catch cancer 10 years early-Click HereYour brain’s power supply may hold the key to mental illness-Click HereNew research reveals how ADHD sparks extraordinary creativity-Click HereThis experimental “super vaccine” stopped cancer cold in the lab-Click HereSports concussions increase injury risk-Click HereUncovering a cellular process that leads to inflammation-Click HereNew study links contraceptive pills and depression-Click HereA short snout predisposes dogs to sleep apnea-Click HereBuilding a new vaccine arsenal to eradicate polio-Click HereThe Viking disease can be due to gene variants inherited from Neanderthals-Click HereQatar Omicron-wave study shows slow decline of natural immunity, rapid decline of vaccine immunity-Click HereMore than a quarter of people with asthma still over-using rescue inhalers, putting them at increased risk of severe attacks-Click hereProgress on early detection of Alzheimer’s disease-Click HereDried samples of saliva and fingertip blood are useful in monitoring responses to coronavirus vaccines-Click HereDietary fiber in the gut may help with skin allergies-Click HereResearchers discover mechanism linking mutations in the ‘dark matter’ of the genome to cancer-Click HereDespite dire warnings, monarch butterfly numbers are solid-Click HereImmunotherapy may get a boost-Click HereArtificial intelligence reveals a never-before described 3D structure in rotavirus spike protein-Click HereRecurring brain tumors shaped by genetic evolution and microenvironment-Click HereCompound shows promise for minimizing erratic movements in Parkinson’s patients-Click HereConsuming fruit and vegetables and exercising can make you happier-Click HereCOVID-19 slows birth rate in US, Europe-Click HereLink between ADHD and dementia across generations-Click HerePreventing the long-term effects of traumatic brain injury-Click HereStudy details robust T-cell response to mRNA COVID-19 vaccines — a more durable source of protection-Click HereArtificial color-changing material that mimics chameleon skin can detect seafood freshness-Click HereNeural implant monitors multiple brain areas at once, provides new neuroscience insights-Click HereB cell activating factor possible key to hemophilia immune tolerance-Click HereMasks not enough to stop COVID-19’s spread without distancing, study finds-Click HereAI can detect COVID-19 in the lungs like a virtual physician, new study shows-Click HerePhase 1 human trials suggest breast cancer drug is safe, effective-Click HereRe-engineered enzyme could help reverse damage from spinal cord injury and stroke-Click HereWeight between young adulthood and midlife linked to early mortality-Click HereIncreased fertility for women with Neanderthal gene, study suggests-Click HereCoronavirus testing kits to be developed using RNA imaging technology-Click HereFacial expressions don’t tell the whole story of emotion-Click HereAcid reflux drug is a surprising candidate to curb preterm birth-Click HereTreating Gulf War Illness With FDA-Approved Antiviral Drugs-Click HereHeart patch could limit muscle damage in heart attack aftermath-Click HereA nap a day keeps high blood pressure at bay-Click HereIn small groups, people follow high-performing leaders-Click HereTick tock: Commitment readiness predicts relationship success-Click HereA comprehensive ‘parts list’ of the brain built from its components, the cells-Click HereResearchers confine mature cells to turn them into stem cells-Click HereNew tissue-imaging technology could enable real-time diagnostics, map cancer progression-Click HereEverything big data claims to know about you could be wrong-Click HerePsychedelic drugs promote neural plasticity in rats and flies-Click HereEducation linked to higher risk of short-sightedness-Click HereNew 3D printer can create complex biological tissues-Click HereThe creative brain is wired differently-Click HereWomen survive crises better than men-Click HerePrecise DNA editing made easy: New enzyme to rewrite the genome-Click HereFirst Time-Lapse Footage of Cell Activity During Limb RegenerationStudy Suggests Approach to Waking Patients After Surgery

Percept: Smart Device for Epilepsy and Movement Disorders

0

NEW HAVEN, Conn. (Ivanhoe Newswire)— A team of neurosurgeons at Yale University are the first in the country to implant a newly approved deep brain stimulation, or DBS, device into a patient with epilepsy. The new device is called Percept and it’s the first system designed to give personalized feedback.

Doctors implant DBS devices in patients to control seizures or the symptoms of Parkinson’s. The DBS is a small, pacemaker-like device that goes under the skin, in the chest, with leads that go to a targeted area of the brain to provide stimulation. But now, this can go one step beyond.

Jason Gerrard, MD, PhD, chief of functional neurosurgery at Yale School of Medicine explained, “What if we could record brain signals from the same electrodes that were doing the brain stimulation?”

(Read Full Interview)

A new neurostimulation device, called Percept with brain sense technology, allows doctors to track patients’ brain signals and match them with a patients’ symptoms or side effects. Right now, a patient has a remote-control device to adjust the stimulation when symptoms start. Doctor Gerrard says the goal is to someday “close the loop” so treatment is automatic.

“So, the patient doesn’t have to think about it. In fact, before they even know that they’re wearing off, the device knows, and it can adjust the stimulation accordingly,” elaborated Dr. Gerrard.

A new and improved device making life better for people with seizures and movement disorders.

The US  Food and Drug Administration approved the new Percept device in June. It’s not only for use in epilepsy patients and those with Parkinson’s, but people with essential tremor, dystonia, and OCD.

Contributors to this news report include: Cyndy McGrath, Executive Producer & Field Producer; Kirk Manson, Videographer; Roque Correa, Editor.

To receive a free weekly e-mail on Medical Breakthroughs from Ivanhoe, sign up at: http://www.ivanhoe.com/ftk

MEDICAL BREAKTHROUGHS

RESEARCH SUMMARY

 

TOPIC:            PERCEPT: SMART DEVICE FOR EPILEPSY AND MOVEMENT DISORDERS

REPORT:        MB #4816

EPILEPSY: Epilepsy is a chronic disorder of recurring and unprovoked seizures. Epileptic seizures may be related to a brain injury or a family tendency, but the cause is often unknown. Many people with epilepsy have more than one type of seizure and may have other neurological problems as well. Sometimes EEG testing, clinical history, family history, and outlook are similar with people who have epilepsy. In these situations, their condition can be defined as a specific epilepsy syndrome. The electrical events that produce the symptoms of a seizure occur in the brain. The location of the event, how it spreads, how much of the brain is affected and how long it lasts all have profound effects. All these factors determine the character of a seizure and its impact on the individual.

(Source: https://www.epilepsy.com/learn/about-epilepsy-basics/what-epilepsy)

DIAGNOSIS AND TREATMENT OF EPILEPSY: Epilepsy is diagnosed if a patient has two unprovoked seizures that were not caused by some known and reversible medical condition like alcohol withdrawal or extremely low blood sugar. To diagnose your condition, a doctor will review your symptoms and medical history. The doctor may order several tests to diagnose epilepsy and determine the cause of seizures. The evaluation may include a neurological exam and blood tests. They may also suggest tests to detect brain abnormalities, such as an Electroencephalogram (EEG), high-density EEG, computerized tomography (CT) scan, magnetic resonance imaging (MRI), functional MRI (fMRI), positron emission tomography (PET), single-photon emission computerized tomography (SPECT), and neuropsychological tests. A doctor might also use analysis techniques to help pinpoint where the seizures start including statistical parametric mapping (SPM) and magnetoencephalography (MEG). An accurate diagnosis of your seizure type and where it begins gives you the best chance for finding an effective treatment. Most people with epilepsy can become seizure-free by taking an anti-seizure medication called anti-epileptic medication. Doctors usually perform surgery when tests show your seizures originated in a small, well-defined area of your brain and the area in your brain does not interfere with vital functions such as speech, language, motor function, vision, or hearing. Other potential therapies that offer an alternative for treating epilepsy are vagus nerve stimulation and ketogenic diet.

(Source: https://www.mayoclinic.org/diseases-conditions/epilepsy/diagnosis-treatment/drc-20350098)

PERCEPT DEVICE: Percept is the first and only deep brain stimulation neurostimulation system with the ability to capture and record brain signals while delivering therapy to patients with neurologic disorders associated with Parkinson’s disease, essential tremor, dystonia, epilepsy or obsessive-compulsive disorder (OCD). Physicians can track patient brain signals and correlate these with patient-recorded symptoms, side-effects, or medication intake. This enables more personalized, data-driven neurostimulation treatment. Dr. Jason Gerrard,  assistant professor of Neurosurgery and Neuroscience at Yale School of Medicine said, “This is going to be extremely helpful for the patients who come in to see their neuro team. The program gets set in the device, stays there, and stimulates like that all the time or the patients will have a couple different programs, and they can change it manually. This is a totally different level of interface with the brain, where the device itself is changing its programming on its own as it senses the patient’s disease state.”

(Sources: http://www.implantable-device.com/2020/06/26/medtronic-receives-approval-for-its-percept-pc-neurostimulator-with-brainsense-technology/#more-2901, Jason Gerrard, MD)

FOR MORE INFORMATION ON THIS REPORT, PLEASE CONTACT:

JENNY CHEN

240-813-8706

JENNY.CHEN@YALE.EDU

If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Marjorie Bekaert Thomas at mthomas@ivanhoe.com

Doctor Q and A

Read the entire Doctor Q&A for Jason Gerrard, MD, PhD, Assistant Professor of Neurosurgery and Neuroscience

Read the entire Q&A